Intelligence · Clinical Pipeline
Ishita Pharma - Pipeline
All ClinicalTrials.gov programs at Ishita Pharma - — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
Ishita Pharma - has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
-, Sodium butyrate 1,1 g/L sol prep
ISTA Pharma Limited
Hirschsprung's disease
1 trial -
KARDEGIC 75 mg, poudre pour solution buvable en sachet-dose, CLOPIDOGREL, CLOPIDOGREL
ISTA Pharma Limited
chronically occluded coronary artery
1 trial -
KVD900 150 mg
ISTA Pharma Limited
Hereditary Angioedema
1 trial -
MYCOHYDRALIN 500 mg, capsule vaginale, FLAGYL 500 mg, comprimé pelliculé, ZITHROMAX 250 mg, comprimé pelliculé, ROCEPHINE 1 g/3,5 ml, poudre et solvant pour solution injectable (IM), GRANUDOXY 100 mg, comprimé pelliculé sécable
ISTA Pharma Limited
Bacterial vaginosis, High risk preterm birth pregnancy, Vaginal flora abnormalities
1 trial -
NICOTINAMIDE, cellulose microcristalline
ISTA Pharma Limited
Acute kidney injury
1 trial -
Randomized control trial comparison between intra-articular infiltrations of PRP, MFAT, and PRP-MFAT in the treatment of symptomatic knee osteoarthritis.
ISTA Pharma Limited
knee osteoarthritis
1 trial -
placebo ketamine inj prep, KETAMINE RENAUDIN 10 mg/ml, solution injectable
ISTA Pharma Limited
Traumatism
1 trial
Frequently asked questions
How many pipeline programs does Ishita Pharma - have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs